Scientists at the Scripps Research Institute have engineered cell-like nanoparticles that target only the immune cells driving an autoimmune reaction, leaving the rest of the immune system intact and healthy. The nanoparticles greatly delayed, and, in some animals, even prevented, severe disease in a mouse model of arthritis. On its surface, each nanoparticle bore copies of a target self-antigen and a sugar-related molecule that can bind to a special “off switch” receptor on B cells, and each nanoparticle also was laced with a powerful compound to stimulate the production of regulatory T cells.
An official website of the United States government.